| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| A800982 | MACKLIN | 氨甲环酸 | 98% | 30元/5g; 59元/25g; 149元/100g; 569元/500g; | 展开 |
|
| A794761 | MACKLIN | 氨甲环酸 | 10mM in Water | 185元/1ml; | 展开 |
|
| A0236 | TCI | trans-4-(Aminomethyl)cyclohexanecarboxylic Acid | >98.0%(GC)(T) | 115元/5G; 395元/25G; 1400元/100G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(GC)(T) | | 分子式/分子量 | C8H15NO2 = 157.21 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 2207452 | | PubChem物质ID | 87561897 | | SDBS (AIST Spectral DB) | 3530 | | Merck Index (14) | 9569 | | MDL编号 | MFCD00001466 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(GC) | min. 98.0 % | | Purity(Nonaqueous Titration) | min. 98.0 % | | Solubility in Water | almost transparency |
物性(参考值) 安全信息 | 图形或危害标志 |  | | 信号词 | 警告 | | 危险性说明 | H315 : 造成皮肤刺激。 H319 : 造成严重眼刺激。
| | 防范说明 | P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/戴防护眼罩/戴防护面具。 P302 + P352 : 如皮肤沾染:用水充分清洗。 P337 + P313 : 如仍觉眼刺激:求医/就诊。 P305 + P351 + P338 : 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P362+P364 : 脱掉沾污的衣服,清洗后方可重新使用。 P332 + P313 : 如发生皮肤刺激:求医/就诊。
|
相关法规 |
| 121740 | J&K | trans-4-(Aminomethyl)cyclohexanecarboxylic Acid | 99% | 155元/10G; 518元/50G; | 展开 |
基本信息 | 分子式 | C8H15NO2 | | 分子量 | 157.21 | | 熔点 | >300 | | MDL编码 | MFCD00001466 | | Beilstein | 2207452 | | Merck | 14,9569 | | EINECS 编号 | 214-818-2 |
安全信息 | 图形或危害标志 |  | | 提示语 | Warning | | 危险说明 | H315 H319 H335 | | 防范说明 | P261 P305+P351+P338 | | WGK | 2 | | RTECS | GU8400000 | | TSCA | 否 |
|
| B21742 | Alfa Aesar | trans-4-(Aminomethyl)cyclohexanecarboxylic Acid | 97% | 1909元/10g; 3557元/50g; 10944元/250g; | 展开 |
应用 It is an antifibrinolytic agent that is found to inhibit plasmin-induced fibrinolysis. Used in various hemorrhagic diseases , abnormal bleeding in operations. It is also used as a lysine analogue to characterize binding sites in plasminogen. 备注 Store away from oxidizing agents. Keep the container tightly closed and place it in a cool, dry and well ventilated condition. 基本信息 MDL MFCD00001466 EINECS 214-818-2 分子式 C8H15NO2 分子量 157.21 熔点 >300° 灵敏度 Ambient temperatures. 形态 Powder 溶解性 Soluble in water (167 mg/ml), ethanol (<1 mg/ml at 25°C). Very slightly soluble in ether, DMSO (<1 mg/ml at 25°C), and alcohol. Beilstein 2207452 Merck 14,9569 GHS危害和防范说明 GHS符号
 Hazard Statements H315-H319-H335 Causes skin irritation.Causes serious eye irritation.May cause respiratory irritation. Precautionary Statements P261-P280a-P305+P351+P338-P304+P340-P405-P501a Avoid breathing dust/fume/gas/mist/vapours/spray.Wear protective gloves and eye/face protection.IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing.Store locked up.Dispose of contents/container in accordance with local/regional/national/international regulations. 安全信息 危险类别 36/37/38 Irritating to eyes, respiratory system and skin. 安全等级 26-37-60 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.This material and its container must be disposed of as hazardous waste RTECS GU8400000 TSCA 否 |
| C22804 | Alfa Aesar | trans-4-(Aminomethyl)cyclohexanecarboxylic Acid | 98+% | 2595元/50g; 10633元/250g; | 展开 |
基本信息 Ref# 22804 MDL 1466 分子式 C8 H15 N O2 分子量 157.21 形态 White powder |
| T1810000 | | Tranexamic Acid | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 20 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 线性分子式 | H2NCH2C6H10CO2H | | 分子量 | 157.21 | | Beilstein | 2207452 | | MDL编号 | MFCD00001466 | | PubChem化学物质编号 | 329826687 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | mp | >300 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | NC[C@H]1CC[C@@H](CC1)C(O)=O | | InChI | 1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)/t6-,7- | | InChI key | GYDJEQRTZSCIOI-LJGSYFOKSA-N | | Gene Information | human ... PLG(5340) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P302 + P352 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1672745 | USP | Tranexamic Acid | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 线性分子式 | H2NCH2C6H10CO2H | | 分子量 | 157.21 | | Beilstein | 2207452 | | MDL编号 | MFCD00001466 | | PubChem化学物质编号 | 329751362 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | mp | >300 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | NC[C@H]1CC[C@@H](CC1)C(O)=O | | InChI | 1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)/t6-,7- | | InChI key | GYDJEQRTZSCIOI-LJGSYFOKSA-N | | Gene Information | human ... PLG(5340) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P302 + P352 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 857653 | Sigma-Aldrich | trans-4-(Aminomethyl)cyclohexanecarboxylic acid | 97% | 487.15元/10 G; 1536.62元/50 G; 5378.61元/250 G; | 展开 |
产品说明 包装 10, 50, 250 g in poly bottle 应用 用作赖氨酸类似物,用于表征纤溶酶原中的结合位点。 基本信息 | 线性分子式 | H2NCH2C6H10CO2H | | 分子量 | 157.21 | | Beilstein | 2207452 | | EC 号 | 214-818-2 | | MDL编号 | MFCD00001466 | | PubChem化学物质编号 | 24888448 | | NACRES | NA.22 |
产品性质 | 质量水平 | 200 | | 测定 | 97% | | mp | >300 ℃ (lit.) | | SMILES string | NC[C@H]1CC[C@@H](CC1)C(O)=O | | InChI | 1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)/t6-,7- | | InChI key | GYDJEQRTZSCIOI-LJGSYFOKSA-N | | Gene Information | human ... PLG(5340) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
| PHR1812 | Supelco | Tranexamic Acid | Pharmaceutical Secondary Standard; Certified Reference Material | 2472.38元/500 MG; | 展开 |
产品说明 一般描述 用于质量控制的制药二级标准品,为制药实验室和制造商提供了一种方便且经济的替代方案,可用于内部工作标准品的制备 应用 氨甲环酸可作为药物参考标准品,通过色谱和分光光度技术对血浆样品、药物制剂和化妆品中的分析物进行测定。 这些二级标准品是合格的认证标准物质(CRM)。它们适用于多种分析应用,包括但不限于药物释放测试、药物的定性和定量分析方法开发、食品和饮料质量控制检测以及其他校准需求。 分析说明 这些二级标准品可追溯至USP、EP和BP一级标准品。 其他说明 该认证参考物质(CRM)根据 ISO 17034和 ISO/IEC 17025进行生产和认证。所有关于客户关系管理的信息都可以在分析证书上找到。 附注 要查看该材料的分析证书示例,请在下面的文档栏中输入LRAC2913。这只是一个示例证书,可能不是您收到的批次。 基本信息 | 线性分子式 | H2NCH2C6H10CO2H | | 分子量 | 157.21 | | Beilstein | 2207452 | | EC 号 | 214-818-2 | | MDL编号 | MFCD00001466 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | 描述 | Pharmaceutical Secondary Standard; Certified Reference Material | | CofA | current certificate can be downloaded | | 包装 | pkg of 500 mg | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | mp | >300 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to PhEur T1810000 traceable to USP 1672745 | | 储存温度 | 2-8℃ | | SMILES string | NC[C@H]1CC[C@@H](CC1)C(O)=O | | InChI | 1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)/t6-,7- | | InChI key | GYDJEQRTZSCIOI-LJGSYFOKSA-N | | Gene Information | human ... PLG(5340) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P280 - P304 + P340 + P312 - P305 + P351 + P338 - P337 + P313 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP734 | | Tranexamic acid impurity standard | British Pharmacopoeia (BP) Reference Standard | 1916.08元/25 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 线性分子式 | H2NCH2C6H10CO2H | | 分子量 | 157.21 | | Beilstein | 2207452 | | MDL编号 | MFCD00001466 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | mp | >300 ℃ (lit.) | | 格式 | mixture | | 储存温度 | 2-8℃ | | SMILES string | NC[C@H]1CC[C@@H](CC1)C(O)=O | | InChI | 1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)/t6-,7- | | InChI key | GYDJEQRTZSCIOI-LJGSYFOKSA-N | | Gene Information | human ... PLG(5340) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H315 - H319 - H335 | | 预防措施声明 | P302 + P352 - P305 + P351 + P338 | | 危险分类 | Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 | | 靶器官 | Respiratory system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 044905 | Fluorochem | trans-4-(Aminomethyl)cyclohexanecarboxylic Acid | 98% | 220元/1g; 220元/5g; 374元/25g; 1254元/100g; | 展开 |
基本信息 | CAS Number | 1197-18-8 | | MDL Number | MFCD00001466 | | Melting Point | >300℃ |
安全信息 | 图形或危害标志 |  | | 危险性说明 | H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing . P264: Wash hands thoroughly after handling. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.. P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see relevant procedures. on this label). P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to in accordance with local regulation .
|
|